Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 6 November 2025
Revised: 29 November 2025
Accepted: 9 December 2025
First Online: 18 December 2025
Competing interests
: MM declares receiving honoraria from Celgene, Amgen, Bristol Myers Squibb, Janssen, Takeda, Pfizer, Novartis, Jazz Pharmaceuticals, Sanofi, Medac; and has a consulting or Advisory Role for Jazz Pharmaceuticals, Sanofi, MaaT Pharma, Novartis, GlaxoSmithKline, Johnson & Johnson/Janssen. TdS and NM declare no relevant conflict of interests in this review.
Free to read: This content has been made available to all.
